GLP-1 supply chain managemen

Diabetes drug distribution used to follow a relatively predictable model. Insulin dominated the biologics segment, oral drugs were handled through conventional wholesale channels, and cold chain requirements were standardized. That model no longer applies the rise of GLP-1 receptor agonists has fundamentally changed diabetes drug logistics. What was once a stable chronic disease distribution system…